Phospholipids in pulmonary drug delivery - Wikidata - wikimedia - TriplyDB

Phospholipids in pulmonary drug delivery

Phospholipids in pulmonary drug delivery

http://www.wikidata.org/entity/Q59089495

about

The future perspectives of natural materials for pulmonary drug delivery and lung tissue engineering.

P2860

Q38293299-2DDF35BA-88BB-46CB-A1FC-40C526EC032B

P2860

Phospholipids in pulmonary drug delivery

http://www.wikidata.org/entity/Q59089495

description

im Juni 2014 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2014

@uk

name

Phospholipids in pulmonary drug delivery

@en

Phospholipids in pulmonary drug delivery

@nl

type

label

Phospholipids in pulmonary drug delivery

@en

Phospholipids in pulmonary drug delivery

@nl

prefLabel

Phospholipids in pulmonary drug delivery

@en

Phospholipids in pulmonary drug delivery

@nl

P1433

Q59089495-20B4F95F-B520-4CC0-A855-71ED12A8D74F

P1476

Q59089495-12FD692B-E096-446E-800D-0B90CFC39C11

P2093

Q59089495-FBCF2648-C884-48EB-8D32-4D7CCC8ECFDF

P2860

Q59089495-04116A4D-56A3-4197-AB53-E93B9233BFC8

Q59089495-0A97810B-AE08-41F0-A117-BD9A432903BB

Q59089495-0E53DF58-B9B6-4E5A-A10C-15C41CD39105

Q59089495-0F3180A3-20D8-45F4-8C1F-83497D6D3610

Q59089495-10CF19CF-94FE-40C0-A10E-D667364DFAA7

Q59089495-12A66605-F958-4DB0-ACE7-D5FA45D02377

Q59089495-16FC1992-B7D5-4148-8E7C-1ACECA6210CD

Q59089495-17A44228-8C70-4E63-8843-BC2D4C313685

Q59089495-1A678361-FA63-442A-9BF3-610BE07C0E6A

Q59089495-1D2CB475-5F1A-4029-B7BD-69224C8CEFE2

P304

Q59089495-A550A63B-5945-4C9C-86B4-D4E087100621

P31

Q59089495-6D03D979-8D92-4B51-A264-CBF922C4E65C

P356

Q59089495-82B87901-A486-44DC-A969-AA18E7D10038

P433

Q59089495-C88D08D4-7C74-47CA-85BA-1520F5D49F0D

P478

Q59089495-AEAF8DCF-8222-4BB2-A3BB-E93766159B65

P50

Q59089495-B9A88FE6-D453-4976-B342-1163E06B89F7

P577

Q59089495-486EF860-225A-42E8-B4D7-E8ABF9A8D566

P921

Q59089495-6B1AEA13-E02A-43AF-A9AB-3E34EECFDDC5

P356

P1433

European Journal of Lipid Science and Technology

P1476

Phospholipids in pulmonary drug delivery

@en

P2093

Karim Amighi

http://www.w3.org/2001/XMLSchema#string

P2860

Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes.

Membrane lipids: where they are and how they behave

Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance.

Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation.

Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment.

Preparation and in vitro evaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy.

Trojan particles: large porous carriers of nanoparticles for drug delivery.

A common pathway for the uptake of surfactant lipids by alveolar cells.

Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.

P304

1114-1128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJLT.201300368

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Nathalie Wauthoz

P577

2014-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921